{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:56:01Z","timestamp":1773932161986,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022QH209"],"award-info":[{"award-number":["ZR2022QH209"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118229","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T23:11:47Z","timestamp":1759360307000},"page":"118229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of benzimidazole-based Mcl-1 inhibitors via AlphaShape-enabled virtual screening"],"prefix":"10.1016","volume":"301","author":[{"given":"Yiming","family":"Nie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8346-9001","authenticated-orcid":false,"given":"Xuben","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118229_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","article-title":"KRAS mutation in pancreatic cancer","volume":"48","author":"Luo","year":"2021","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118229_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1158\/1535-7163.MCT-21-0474","article-title":"Overcoming gemcitabine resistance in pancreatic cancer using the BCL-X(L)-Specific degrader DT2216","volume":"21","author":"Thummuri","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.118229_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118229_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.118229_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving outcomes of patients with pancreatic cancer","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118229_bib6","article-title":"Targeting active RAS with molecular glue","volume":"2","author":"Su","year":"2024","journal-title":"Pharmaceut. Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118229_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113038","article-title":"Development of Mcl-1 inhibitors for cancer therapy","volume":"210","author":"Negi","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib8","article-title":"Novel targeted therapies in chronic myeloid leukemia","volume":"2","author":"Ashaq","year":"2024","journal-title":"Pharmaceut. Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.118229_bib9","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1111\/febs.14505","article-title":"Phosphorylation alters bim-mediated Mcl-1 stabilization and priming","volume":"285","author":"Conage-Pough","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118229_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.6","article-title":"Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer","volume":"5","author":"Nakajima","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118229_bib11","doi-asserted-by":"crossref","first-page":"17802","DOI":"10.1074\/jbc.M114.548172","article-title":"The carboxyl-terminal tail of Noxa protein regulates the stability of Noxa and Mcl-1","volume":"289","author":"Pang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib12","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1021\/acs.jcim.7b00396","article-title":"Toward understanding Mcl-1 promiscuous and specific binding mode","volume":"57","author":"Fogha","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118229_bib13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2174\/1568009618666180308105048","article-title":"Noxa: role in cancer pathogenesis and treatment","volume":"18","author":"Morsi","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejmech.2025.118229_bib14","article-title":"Inhibition of anti-apoptotic Bcl-2 proteins in preclinical and clinical studies: current overview in cancer","volume":"9","author":"D'Aguanno","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.118229_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100672","article-title":"Targeting MCL-1 in hematologic malignancies: rationale and progress","volume":"44","author":"Wei","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.ejmech.2025.118229_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/mol.119.116855","article-title":"CDK5 inhibitor downregulates Mcl-1 and sensitizes pancreatic cancer cell lines to navitoclax","volume":"96","author":"Kour","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118229_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1476-4598-12-105","article-title":"miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death","volume":"12","author":"Chen","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2025.118229_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00280-008-0697-7","article-title":"Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell","volume":"62","author":"Wei","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118229_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.surg.2009.10.033","article-title":"Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo","volume":"147","author":"Guoan","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.ejmech.2025.118229_bib20","doi-asserted-by":"crossref","first-page":"13925","DOI":"10.1021\/acs.jmedchem.4c00643","article-title":"Discovery of novel Mcl-1 inhibitors with a 3-Substituted-1H-indole-1-yl moiety binding to the P1-P3 pockets to induce apoptosis in acute myeloid leukemia cells","volume":"67","author":"Deng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117168","article-title":"Chemical dissection of selective myeloid leukemia-1 inhibitors: how they were found and evolved","volume":"283","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib22","doi-asserted-by":"crossref","first-page":"14370","DOI":"10.1021\/acs.jmedchem.4c01188","article-title":"Discovery of a myeloid cell leukemia 1 (Mcl-1) inhibitor that demonstrates potent activities in mouse models of hematological and solid tumors","volume":"67","author":"Tarr","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib23","doi-asserted-by":"crossref","first-page":"27369","DOI":"10.1021\/acsomega.4c02021","article-title":"Discovery of phenylpyrazole derivatives as a new class of selective inhibitors of MCL-1 with antitumor activity","volume":"9","author":"Gong","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118229_bib24","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1021\/acs.jmedchem.3c01998","article-title":"Targeting myeloid Leukemia-1 in cancer therapy: advances and directions","volume":"67","author":"Deng","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1021\/acs.jmedchem.9b00983","article-title":"Hot-spots of Mcl-1 protein","volume":"63","author":"Denis","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib26","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41467-024-45766-2","article-title":"Design of target specific peptide inhibitors using generative deep learning and molecular dynamics simulations","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118229_bib27","doi-asserted-by":"crossref","first-page":"18633","DOI":"10.1021\/acs.jmedchem.4c02462","article-title":"Current status of computational approaches for small molecule drug discovery","volume":"67","author":"Xu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib28","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1021\/acs.jcim.4c00072","article-title":"Docking score ML: target-specific machine learning models improving docking-based virtual screening in 155 targets","volume":"64","author":"Liu","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118229_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112131","article-title":"Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets","volume":"190","author":"Hou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4155\/fmc-2020-0114","article-title":"Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors","volume":"12","author":"Du","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112142","article-title":"Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors","volume":"191","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib32","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1021\/acs.jmedchem.2c00164","article-title":"Electrostatic complementarity in structure-based drug design","volume":"65","author":"Cons","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib33","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1021\/ci300601q","article-title":"Enhancing molecular shape comparison by weighted Gaussian functions","volume":"53","author":"Yan","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118229_bib34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/jcc.23603","article-title":"gWEGA: GPU-accelerated WEGA for molecular superposition and shape comparison","volume":"35","author":"Yan","year":"2014","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib35","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/acsmedchemlett.7b00100","article-title":"Synthesis and investigation of S-Substituted 2-Mercaptobenzoimidazoles as inhibitors of Hedgehog signaling","volume":"8","author":"Gr\u00e4\u00dfle","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118229_bib36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1021\/jm00083a007","article-title":"Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis","volume":"35","author":"Reich","year":"1992","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib37","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/cmdc.202000822","article-title":"Heteroaromatic inhibitors of the astacin proteinases meprin \u03b1, meprin \u03b2 and ovastacin discovered by a scaffold-hopping approach","volume":"16","author":"Tan","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118229_bib38","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1021\/acs.joc.8b02750","article-title":"Development of a convergent large-scale synthesis for venetoclax, a first-in-class BCL-2 selective inhibitor","volume":"84","author":"Ku","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113047","article-title":"18F-labeled radiotracers for in vivo imaging of DREADD with positron emission tomography","volume":"213","author":"Hu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/jm301448p","article-title":"Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design","volume":"56","author":"Friberg","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib41","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/acs.jmedchem.5b01660","article-title":"Discovery of 2-Indole-acylsulfonamide myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods","volume":"59","author":"Pelz","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib42","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1021\/jm501984f","article-title":"Discovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based design","volume":"58","author":"Burke","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib43","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1039\/D2MD00095D","article-title":"Scaffold hopping from indoles to indazoles yields dual MCL-1\/BCL-2 inhibitors from MCL-1 selective leads","volume":"13","author":"Drennen","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-024-00814-0","article-title":"BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models","volume":"5","author":"Rauh","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejmech.2025.118229_bib45","article-title":"Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients","volume":"3","author":"Yuda","year":"2023","journal-title":"Commun. Med-London"},{"key":"10.1016\/j.ejmech.2025.118229_bib46","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/acs.jmedchem.3c02206","article-title":"Development of potent Mcl-1 inhibitors: structural investigations on macrocycles originating from a DNA-encoded chemical library screen","volume":"67","author":"Hekking","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118229_bib47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1158\/1535-7163.MCT-12-0767","article-title":"A novel small-molecule inhibitor of Mcl-1 blocks pancreatic cancer growth and","volume":"13","author":"Abulwerdi","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.118229_bib48","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1021\/acs.jcim.3c00227","article-title":"Deciphering the allosteric activation mechanism of SIRT6 using molecular dynamics simulations","volume":"63","author":"Zhao","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118229_bib49","article-title":"Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation","volume":"6","author":"Hou","year":"2016","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.ejmech.2025.118229_bib50","doi-asserted-by":"crossref","first-page":"W537","DOI":"10.1093\/nar\/gks375","article-title":"++3.0: automating prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations","volume":"40","author":"Anandakrishnan","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118229_bib51","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118229_bib52","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/cmdc.201000484","article-title":"Discovery and development of Thiazolo[3,2-]pyrimidinone derivatives as general inhibitors of Bcl-2 family proteins","volume":"6","author":"Zhou","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118229_bib53","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/cmdc.201500461","article-title":"Structural Re-engineering of the alpha-Helix mimetic JY-1-106 into small molecules: disruption of the Mcl-1-Bak-BH3 protein-protein interaction with 2,6-Di-Substituted nicotinates","volume":"11","author":"Drennen","year":"2016","journal-title":"ChemMedChem"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:05:02Z","timestamp":1773147902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":53,"alternative-id":["S0223523425009948"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118229","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of benzimidazole-based Mcl-1 inhibitors via AlphaShape-enabled virtual screening","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118229"}}